Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Gene Variations Can Be Barometer Of Behavior, Choices
Researchers at Brown University and the University of Arizona have determined that variations of three different genes in the brain (called single-nucleotide polymorphisms) may help predict a person"s tendency to make certain choices.

As They Debate Health Overhaul, Politicians Keep Eye On 2010
"Fifteen months before the midterm congressional election, health care is appearing in candidate stump speeches and interviews - particularly by Republican challengerṣ€¦ running in districts recently claimed by Democrats," USA Today reports. "That dynamic helps explain why a $1 trillion-plus health care bill stalled last week in Congress. ̣€¦ Obama has said he wants lawmakers to finish health care by the end of the year, in part because it could become mired in election-year politics. All 435 members of the House and 36 members of the Senate are up for election in 2010."
News of the day
Mindblind Eyes: An Absence Of Spontaneous Theory Of Mind In Asperger Syndrome
Highly intelligent adults with Asperger Syndrome still have difficulties in day-to-day social interaction. These difficulties may be explained by "mindblindness", the idea that they are unable to predict what other people will do by thinking about their mental states, that is, their knowledge and beliefs. If this is true then why do people with Asperger syndrome pass all the standard tests of mental state attribution? Is the theory wrong or are the tests insensitive? This study reports evidence from eye movements, that adults with Asperger Syndrome do not spontaneously anticipate another person"s behaviour on the basis of that person"s mental state. This is in stark contrast with typical adults, and even young toddlers.
Sexual Health

Impax Receives FDA Approval For Generic Precose(R) Tablets, 25 Mg, 50 Mg And 100 Mg

Impax Laboratories, Inc. (NASDAQ: IPXL) confirmed that the U.S. Food and Drug Administration (FDA) has granted approval of the Company"s Abbreviated New Drug Application (ANDA) for generic versions of Precose® Tablets (acarbose), 25 mg, 50 mg and 100 mg strengths. Precose®, a Bayer HealthCare Pharmaceuticals product, is used in the management of type two diabetes mellitus. The Company expects to launch all strengths in the fourth quarter of 2009, through Global Pharmaceuticals, Impax"s generic division. According to Wolters Kluwer Health, U.S. generic and brand sales for Acarbose 25 mg, 50 mg and 100 mg tablets were approximately $32 million for the 12 months ended March 2009. Impax Laboratories, Inc.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009